Cart
sales@molnova.com
Fosifidancitinib
CAS No. 1237168-58-9
Fosifidancitinib( —— )
Catalog No. M28194 CAS No. 1237168-58-9
Fosifidancitinib is a potent inhibitor of JAK 1 and JAK 3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 120 | In Stock |
|
| 5MG | 187 | In Stock |
|
| 10MG | 283 | In Stock |
|
| 25MG | 452 | In Stock |
|
| 50MG | 631 | In Stock |
|
| 100MG | 848 | In Stock |
|
| 200MG | 1135 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFosifidancitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionFosifidancitinib is a potent inhibitor of JAK 1 and JAK 3.
-
DescriptionFosifidancitinib is a potent inhibitor of JAK 1 and JAK 3.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1237168-58-9
-
Formula Weight505.39
-
Molecular FormulaC21H21FN5O7P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1cc(Nc2ncc(C)c(Nc(cc3)cc(N4COP(O)(O)=O)c3OC4=O)n2)cc(OC)c1F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kungl AJ, et al. Molecular dynamics simulation of the rare amino acid LL-dityrosine and a dityrosine-containing peptide: comparison with time-resolved fluorescence. Biochim Biophys Acta. 1994 Dec 15;1201(3):345-52.
molnova catalog
related products
-
JAK1-IN-31
JAK1-IN-31 is a potent and selective JAK1 inhibitor with Ki of 1.9 nM.
-
Decernotinib
Decernotinib (VX-509, VRT-831509) is a potent, selective, orally available JAK3 inhibitor with Ki of 2.5 nM and cellular IC50 of 50-170 nM.
-
Tofacitinib citrate
A potent, specific, orally active inhibitor of JAK3 with IC50 of 1 nM in cell-free assays; displays 20- to 100-fold less potency for JAK2 and JAK1 (IC50=20 nM and 112 nM, respectively).
